MuSK-antibody positive myasthenia gravis: questions from the clinic.
Clinical vignettes are presented of five patients with MuSK-antibody positive myasthenia gravis, each of which demonstrates a diagnostic or therapeutic issue that is unique to or characteristic of this condition. Consideration of these issues leads to questions, many of which are unanswered at this time, about the immunopathology and management of this subset of myasthenia gravis.
Sanders
Donald B
DB
Duke University Medical Center, Durham, NC 27710, USA. Donald.Sanders@Duke.edu
Juel
Vern C
VC
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000906:Antibodies / Q000097:blood*; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*
D000906:Antibodies; D011950:Receptors, Cholinergic; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases